Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Harvard Bioscience Sees Q2 Sales $18.000M-$20.000M vs $19.20M Est

Author: Benzinga Newsdesk | May 12, 2025 06:03am

Harvard Bioscience (NASDAQ:HBIO) sees Q2 sales of $18.000 million-$20.000 million vs $19.20 million analyst estimate.

Posted In: HBIO